Latest Asx News

Cyprium Metals completed a A$15 million capital raise and formed a strategic alliance with Macmahon to accelerate the restart of its Nifty Copper Complex, while upgrading its Maroochydore copper-cobalt resource.

Mesoblast has commercially launched Ryoncil in the US for pediatric acute GVHD, backed by a strong cash position and advancing multiple cell therapy programs.

North Stawell Minerals Ltd reported a significant reduction in cash reserves for the quarter ending March 2025, highlighting a potential capital raising as exploration activities near completion.

Terra Uranium Limited has completed its acquisition of LCT Metals, gaining control of significant tin and precious metals projects in New South Wales, diversifying its portfolio beyond uranium. The company plans to leverage historical data to advance exploration and drilling in these high-grade zones amid favorable tin market conditions.

Hydrix Limited reports improved operating performance in Q3 FY25, buoyed by FDA clearance of its Gyder Surgical Hip Navigation system and a reduced cash operating loss, while managing tight liquidity with shareholder support.

West Cobar Metals has identified five high-priority copper-gold targets in Western Australia’s Fraser Range and secured a farm-in deal with Minrex Resources to fund upcoming drilling. Positive metallurgical results at its Bulla Park copper-antimony project and a $450,000 placement underpin its exploration momentum.

Eneco Refresh Limited reports solid 8% year-to-date revenue growth for Q3 FY2025, underpinned by gains in its water and plastics segments and improved cash flow.

Elixinol Wellness reported a 13.7% year-on-year revenue increase in Q1 FY25, despite a softer quarter compared to record Q4, with ecommerce momentum and strategic initiatives setting the stage for margin recovery and growth in H2.

The Star Entertainment Group reported a 9% revenue decline to $271 million in Q3 FY25 alongside a $21 million EBITDA loss, driven by seasonal factors and operational challenges. The company is advancing strategic investments and joint venture exits amid ongoing liquidity pressures and regulatory hurdles.

North Stawell Minerals has reported a standout high-grade gold intercept at its Darlington target, reinforcing the potential for a Mariners-type mineralisation repeat in Victoria’s Stawell Corridor. Meanwhile, Wildwood drilling confirms geological promise despite lower grades.

Avecho Biotechnology has inked a decade-long exclusive licensing agreement with Sandoz for its pharmaceutical-grade cannabidiol capsule targeting insomnia in Australia, backed by a US$3 million upfront payment and promising milestone and royalty streams.

Lode Resources has reported exceptional high-grade antimony and silver drill results from its Montezuma Project in Tasmania, alongside commencing a substantial 50-60 hole drilling program to expand the deposit.